CYTOKINETICS INC (CYTK) › Shareholders' EquityCYTOKINETICS INC (CYTK) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.1998: -$2.00M1999: -$9.12M2000: -$21.82M2001: -$37.35M2002: -$60.59M2003: -$92.03M2004: $107.56M2005: $73.56M2006: $106.31M2007: $99.92M2008: $49.77M2009: $101.43M2010: $70.52M2011: $48.18M2012: $70.08M2013: $54.44M2014: $92.06M2015: $68.59M2016: $94.36M2017: $109.84M2018: $25.93M2019: -$10.94M2020: $113.38M2021: $243.86M2022: -$107.90M2023: -$386.32M2024: -$135.37M2025: -$659.62M-$659.62M1998Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$659.62M-387.3%2024-$135.37M+65.0%2023-$386.32M-258.0%2022-$107.90M-144.2%2021$243.86M+115.1%2020$113.38M+1136.7%2019-$10.94M-142.2%2018$25.93M-76.4%2017$109.84M+16.4%2016$94.36M+37.6%2015$68.59M-25.5%2014$92.06M+69.1%2013$54.44M-22.3%2012$70.08M+45.5%2011$48.18M-31.7%2010$70.52M-30.5%2009$101.43M+103.8%2008$49.77M-50.2%2007$99.92M-6.0%2006$106.31M+44.5%2005$73.56M-31.6%2004$107.56M+216.9%2003-$92.03M-51.9%2002-$60.59M-62.2%2001-$37.35M-71.2%2000-$21.82M-139.2%1999-$9.12M-354.9%1998-$2.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share